The balance of A-share financing reached a new high in nine years. Since the fourth quarter, the net purchase amount of financing in 12 industries has exceeded 10 billion yuan. As of December 12, the balance of A-share financing was 1,882.656 billion yuan, a new high since August 2015. Since the fourth quarter, the market financing balance has grown rapidly. The latest financing balance was 1,882.656 billion yuan, an increase of 452.006 billion yuan or 31.59% compared with the financing balance of 1,430.650 billion yuan on September 30. During the period, the net purchase amount of financing in 12 industries exceeded 10 billion yuan. Electronics, computers, non-bank finance and machinery and equipment ranked in the top four, with the amounts of 77.849 billion yuan, 50.709 billion yuan, 49.201 billion yuan and 31.068 billion yuan in turn. In proportion, the latest financing balance of electronics, mechanical equipment and computers increased by more than 50% compared with that before the fourth quarter; The growth rate of media, communications and automobiles is also higher than 40%. In terms of individual stocks, Oriental Fortune received the most financing customers, with a net purchase amount of 15.892 billion yuan; SMIC ranked second with a net purchase of 5.515 billion yuan; Jianghuai Automobile ranked third with a net purchase of 4.122 billion yuan. Among the TOP20 stocks, there are many non-bank financial, automobile, computer and semiconductor stocks, accounting for 50% of the total. (data treasure)Nearly 30 listed companies announced after-hours that their products would be selected, and the tenth batch of centralized drug procurement (centralized drug procurement) organized by the state was opened in Shanghai yesterday. According to incomplete statistics, as of press time, it includes Fuyuan Pharmaceutical, Yifan Pharmaceutical, ST Tiansheng, Hokuriku Pharmaceutical, Haizheng Pharmaceutical, Zhongheng Group, Yuandong Bio, Kelun Pharmaceutical, China Resources Shuanghe, Sinopharm Modern, Lingkang Pharmaceutical, Xuantai Pharmaceutical, Jiuzhou Pharmaceutical, Kang Enbei, Laimei Pharmaceutical, Kanghong Pharmaceutical, Huasen Pharmaceutical, Borui Pharmaceutical, Xianzeng Pharmaceutical. Among them, Kelun Pharmaceutical announced that 12 kinds of drugs, such as sodium acetate Ringer injection, sodium bicarbonate Ringer injection and gliclazide tablets, were to be selected.The self-built valuation model of bank wealth managers has met with "standardization": some institutions have re-adopted the strategy of excess return of the bank's tier-2 capital bonds with the valuation system of China Securities and China Securities, and recently, the regulatory authorities issued a document to the bank wealth management subsidiary, demanding that the self-built valuation model should not be used to smooth the net value fluctuation, and the valuation standards provided by third parties such as China Securities and China Securities should be adopted, and self-inspection and rectification should be carried out. The purpose of this move is to prevent the bank's wealth management subsidiaries from adjusting product income through self-built models, and to carry out "fund pool" business in disguise to ensure market fairness. At present, a number of bank wealth management subsidiaries have received this document, and have begun to adjust the net value calculation methods of day-opening and closed wealth management products, and re-adopt third-party valuation for investment products such as bank tier 2 capital bonds. A person from a bank financing subsidiary told reporters that he heard that the financial supervision department held a small-scale meeting last week, asking the bank financing subsidiary to respect the new asset management rules and not to violate accounting standards. In addition, the relevant departments also require the financial subsidiaries of banks that have used the self-built valuation model to carry out rectification, and the financial subsidiaries that have been notified shall submit corresponding rectification plans and measures reports within one month. In the view of the above-mentioned bank wealth managers, it is not excluded that some bank wealth management subsidiaries have lowered the allocation ratio of bank tier-2 capital bonds due to the influence of regulatory policies, because when the self-built valuation model is "standardized", the strategy of over-allocating bank tier-2 capital bonds to obtain excess returns becomes increasingly difficult when the net product value fluctuates relatively smoothly. (per meridian)
Jinghe Jicheng: Shareholder Lijing Venture Capital intends to transfer 1.50% shares of the company by inquiry, and Jinghe Jicheng announced that shareholder Lijing Venture Capital intends to transfer 30.092 million shares of the company by inquiry transfer, accounting for 1.50% of the company's total share capital.The Chairman of the Sudan Sovereignty Committee and the Turkish President made a phone call focusing on the situation in Sudan. On December 13th, local time, Borhan, Chairman of the Sudan Sovereignty Committee and Commander-in-Chief of the Armed Forces, made a phone call with Turkish President Erdogan, focusing on the situation in Sudan. Erdogan said during the call that Turkey is willing to mediate between Sudan and the United Arab Emirates to resolve the contradictions between the two countries. Since the outbreak of armed conflict in Sudan last year, Sudanese government officials have repeatedly accused the UAE government of supporting the Sudan Rapid Support Force, which has caused tension between the two countries. At the end of last year, the two countries expelled each other's diplomats. Erdogan also said that Turkey opposes foreign interference in Sudan's internal affairs and supports Sudan in safeguarding national unity and territorial integrity and restoring peace and stability. (CCTV News)Peng Qinghua met with Babacov, Vice Chairman of Russian State Duma, and Peng Qinghua, Vice Chairman of the National People's Congress Standing Committee (NPCSC), met with Babacov, Vice Chairman of Russian State Duma, in Beijing on the 13th. The two sides indicated that they will jointly implement the important consensus reached by the two heads of state, make good use of the platform of the joint working group of the Sino-Russian Parliamentary Cooperation Committee, deepen exchanges and cooperation between legislative bodies, and promote the further development of China-Russia comprehensive strategic partnership of cooperation in the new era. (Xinhua News Agency)
Musk received an ultimatum from the SEC or faced multiple accusations, and the long-term confrontation between the US SEC and Musk escalated again. On December 12th, local time, Alex spiro, a lawyer of Musk, wrote to Gary Gensler, the outgoing chairman of the SEC, accusing the agency of launching an "ulterior motive action" against Musk, and revealed that the SEC had restarted the investigation of Neuralink, a brain-computer interface company owned by Musk. According to the contents of the letter, the SEC asked Musk to accept the settlement agreement within 48 hours and pay the fine, otherwise he would face "multiple accusations". These allegations are related to Musk's stock investment behavior before the acquisition of Twitter (now "X") in 2022, involving trading time and the legality of information disclosure. It was mentioned in the letter that the accusation originated from an investigation that lasted for several years, and the SEC recently issued a subpoena to Musk's lawyer, asking him to provide testimony. Alex spiro said that he had explicitly refused to cooperate and accused the agency of "political motives". Musk also posted a letter from his lawyer to Gary Gensler on social media, with the text "Gary, how could you do this to me" and a crying emoji. Alex spiro also asked in his letter who was directing the SEC's actions. Alex spiro emphasized that the SEC's "harassment" of Musk and its affiliates for six years has deviated from the original intention of seeking the truth and become an improper pressure. At present, the SEC has not commented on this. In addition, the letter said that the SEC also restarted the investigation of Neuralink, a brain-computer interface company owned by Musk. This autumn, the animal protection organization "Committee of Responsible Medical Doctors" and four US congressmen asked the SEC to investigate Neuralink, accusing it of securities fraud through misleading propaganda. (Securities Times)Shenzhen sub-district strong monsoon blue warning signal, Shenzhen Meteorological Observatory issued strong monsoon blue warning signals for Luohu District, Yantian District, Dapeng New District, Dapeng Bay and Daya Bay at 21: 20 on December 13, 2024. Due to the influence of cold air, the maximum gust in the above areas is expected to be 7-8, and the signal may last until the morning of the 15th. Please implement various wind protection measures.Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide